MOLLIE DOTY: Open Payments
NPI 1457398729 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,889 in 149 payments from 20 companies in 2025. Trend: 2023 $2,533 · 2024 $2,234 · 2025 $2,889
Food & beverage: $2,789Education: $100
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 36 | $714 |
| Mallinckrodt Hospital Products Inc. | 15 | $391 |
| AstraZeneca Pharmaceuticals LP | 19 | $372 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $224 |
| Regeneron Healthcare Solutions, Inc. | 8 | $210 |
| GENZYME CORPORATION | 10 | $207 |
| Viatris Specialty LLC | 13 | $174 |
| Verona Pharma, Inc. | 13 | $143 |
| Merck Sharp & Dohme LLC | 4 | $96 |
| United Therapeutics Corporation | 3 | $77 |
Products named: DUPIXENT, ACTHAR, NUCALA, TRELEGY ELLIPTA, YUPELRI, BREZTRI, Ohtuvayre, AIRSUPRA.
Industry payments across MS — which companies pay providers there.
